Richard J. Daly, CEO of Catalyst Pharmaceuticals, will present at the J.P. Morgan Healthcare Conference on January 16, 2025.Quiver AI SummaryCatalyst Pharmaceuticals, Inc. announced that Richard J. Daly,...
GARY INGENITO, the Chief Med. & Reg. Officer of $CPRX ($CPRX), sold 3,369 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.2%...
Catalyst Pharmaceuticals ranked 452 on Deloitte's Technology Fast 500 for achieving 234% revenue growth from 2020 to 2023.Quiver AI SummaryCatalyst Pharmaceuticals, Inc. announced that it ranked number...
PATRICK J MCENANY, a director at $CPRX ($CPRX), sold 72,500 shares of the company on 11-20-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.6% of their shares....
For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...
The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...